How Life Insurance Tests for Tobacco and Nicotine Use

Tobacco and nicotine testing is a standard part of life insurance underwriting because tobacco use is one of the most significant rating factors, typically doubling to quadrupling premiums. Carriers use multiple methods to detect tobacco use, making it virtually impossible to conceal. Understanding these testing methods and their implications helps you approach the underwriting process honestly and with realistic expectations about how tobacco use affects your coverage options.

Cotinine testing is the primary method. Cotinine is a metabolite of nicotine that remains detectable in the body for 7-10 days after tobacco use. Both blood and urine samples collected during the medical exam are tested for cotinine. The test can detect cigarettes, cigars, pipes, chewing tobacco, nicotine patches, nicotine gum, and e-cigarettes/vaping products. The sensitivity of modern cotinine testing means that even occasional use will be detected if the exam occurs within the detection window. The threshold levels used by carriers are calibrated to distinguish active use from incidental secondhand smoke exposure.

Prescription database checks may reveal nicotine replacement therapy prescriptions (patches, gum, Chantix/Wellbutrin for smoking cessation), indicating recent or current tobacco use. Even if you test negative for cotinine, a prescription for smoking cessation medication in your database raises the question of when you last used tobacco. Some carriers view cessation medications positively as evidence of quitting, while others view them as evidence of recent use.

MIB records from previous insurance applications may contain tobacco-use flags from earlier testing or disclosures. If you disclosed tobacco use on a prior application within the past seven years, that information is coded in the MIB database and visible to future carriers. This means that even if you have quit and test clean, past disclosures may prompt additional questions.

Medical records obtained through the Attending Physician Statement (APS) may document tobacco use in physician notes, smoking cessation counseling, or lung-related conditions. Physician notes frequently record smoking status as part of routine visits, creating a documented history of tobacco use that extends well beyond the cotinine detection window.

False positives are rare but can occur — exposure to secondhand smoke does not typically cause a positive cotinine test at standard thresholds. Certain foods, supplements, and medications can occasionally produce false positives, though this is uncommon with modern testing methods. If you believe a test result is inaccurate, you can request retesting, and agents in our network can facilitate this process with the carrier.

The financial incentive for honesty is clear: misrepresenting tobacco use on the application and being caught through testing results in immediate reclassification to smoker rates. Worse, if undisclosed tobacco use is discovered after a claim during the contestability period, the claim may be denied entirely. The risk of misrepresentation far outweighs the benefit, as the consequences extend beyond higher premiums to potential loss of the death benefit when your family needs it most.

For current tobacco users planning to quit, most carriers require 12 months of tobacco-free status (verified by clean cotinine testing) to qualify for non-smoker rates. Some carriers require longer periods — 2 to 5 years — for the best classifications like Preferred Plus. If you have recently quit, consider the timing of your application carefully. Applying too early means smoker rates; waiting until you have a clean testing history allows access to significantly lower non-smoker premiums. An agent in our network can advise on the optimal timing for your specific situation and carrier options.